Literature DB >> 3426095

The role of CT in the management of carcinoma of the oesophagus and cardia.

J P Duignan1, G P McEntee, D J O'Connell, D J Bouchier-Hayes, E O'Malley.   

Abstract

The role of computed tomography in assessing tumour spread and tumour resectability was evaluated in 50 patients with oesophageal carcinoma (17 middle third, 33 lower third). CT accurately identified all patients with tumour confined to the oesophagus (Stage I or II) but was limited in its ability to assess direct organ invasion (Stage III) with an overall accuracy for evaluating middle third lesions of 82% (aorta 70%, tracheobronchial tree 94%, other mediastinal structures 82%) compared to an overall accuracy for lower third lesions of 97% (aorta 97%, pancreas 100%, diaphragm 97%). Tumours deemed resectable on CT were always resectable at operation but two of seven middle third tumours and one of twelve lower third lesions deemed unresectable underwent curative resection. Preoperative CT evaluation of oesophageal tumours is useful in that it may reliably identify tumour lesions confined to the oesophagus and reliably identify distant metastases. Because of its limitations however in the assessment of organ invasion, particularly by middle third lesions, this study suggests that patients with oesophageal tumours with no evidence of distant metastases, who are otherwise fit to undergo tumour resection, should not be denied surgery on the sole basis of positive organ invasion on CT particularly if that organ is the aorta.

Entities:  

Mesh:

Year:  1987        PMID: 3426095      PMCID: PMC2498521     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  14 in total

1.  Palliative dilation of esophageal carcinoma.

Authors:  F M Moses; D A Peura; R K Wong; L F Johnson
Journal:  Gastrointest Endosc       Date:  1985-04       Impact factor: 9.427

2.  Esophageal cancer staging by CT: long-term follow-up study.

Authors:  R A Halvorsen; K Magruder-Habib; W L Foster; L Roberts; R W Postlethwait; W M Thompson
Journal:  Radiology       Date:  1986-10       Impact factor: 11.105

3.  Endoscopic Nd:YAG laser therapy as palliation for esophagogastric cancer. Parameters affecting initial outcome.

Authors:  D Fleischer; M V Sivak
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

4.  CT assessment of operability in carcinoma of the oesophagogastric junction.

Authors:  F Terrier; C Schapira; W A Fuchs
Journal:  Eur J Radiol       Date:  1984-05       Impact factor: 3.528

5.  Computed tomography in the staging of esophageal carcinoma.

Authors:  D Picus; D M Balfe; R E Koehler; C L Roper; J W Owen
Journal:  Radiology       Date:  1983-02       Impact factor: 11.105

6.  Reappraisal of esophagogastrectomy for esophageal malignancy.

Authors:  V A Piccone; H H LeVeen; N Ahmed; S Grosberg
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

7.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  A L Ogilvie; M W Dronfield; R Ferguson; M Atkinson
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

8.  Esophageal carcinoma: pretherapy staging by computed tomography.

Authors:  A A Moss; P Schnyder; R F Thoeni; A R Margulis
Journal:  AJR Am J Roentgenol       Date:  1981-06       Impact factor: 3.959

9.  Tube introducer and modified Celestin tube for use in palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  M Atkinson; R Ferguson; G C Parker
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

Review 10.  Role of the CT scanner in the management of cancer.

Authors:  J E Husband
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16
View more
  1 in total

1.  Combined resection of the aorta for an esophageal carcinoma invading the aorta through a right transthoracic approach.

Authors:  T Kabuto; T Yasuda; H Furukawa; M Higashiyama; K Takami; H Yokouchi; K Kodama; H Takami; T Kobayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.